No clear answer
Interferon beta: slow disability worsening in relapsing and progressive MS
relapsing and progressive MS · Interferon beta
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 2
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
No controlled trial has reported a result yet.
Other linked trials: 2
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 2
These linked trials do not set the status.
- Combination Therapy of Betaseron-Prograf in Multiple SclerosisMain goal was not benefit (e.g. safety)
Phase 2 · 2003 · Not randomised
- TOLERVIT-MSResult in a paper, not read yet
Phase 1 · 2017 · Not randomised
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-30Trials: 4 → 2
- 2026-10-30Status changed from Mixed to No clear answer
- 2026-10-27First listed as Mixed
Related hypotheses
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error